+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Adverse drug reaction reporting in institutions across six Chinese provinces: a cross-sectional study

Adverse drug reaction reporting in institutions across six Chinese provinces: a cross-sectional study

Expert Opinion on Drug Safety 2018: 1-10

Although China's adverse drug reaction (ADR) reporting and monitoring has developed rapidly, many challenges remain. This study assessed ADR monitoring and reporting in China and identified monitoring problems. A cross-sectional survey was conducted of ADR reporting institutions in six Chinese provinces in April-December 2014. Questionnaires assessed ADR systems, basic resources, and pharmacovigilance activity. Of 720 questionnaires distributed, the response rate was 81.8%. About 93% (n = 371) of pharmaceutical companies and medical institutions had established ADR monitoring departments/units. Few institutions (26%, n = 104) allocated an ADR budget; 7% (n = 30) had received ADR monitoring funding in the last year (2013). Almost all institutions (99%, n = 555) had computers and 47% (n = 263) had a network database. Many institutions conducted public education about drug safety (49%, n = 283), medicine utilization reviews/quality surveys (28%, n = 158), and medicine consultation services (88%, n = 511). Institutions in eastern, central, and western China differed significantly on implementation of existing regulations and pharmacovigilance activities. The institutions surveyed have established ADR monitoring systems. However, these systems have flaws. Urgent improvements are needed in funding, basic resources, reporting processes, and other pharmacovigilance activities.

(PDF emailed within 0-6 h: $19.90)

Accession: 045405671

Download citation: RISBibTeXText

PMID: 29883236

DOI: 10.1080/14740338.2018.1486820

Related references

Knowledge, Attitude, and Practices regarding Pharmacovigilance and Adverse Drug Reaction reporting among Dental Students in a Teaching Hospital, Jodhpur, India: A Cross-sectional Study. Journal of Contemporary Dental Practice 18(10): 964-969, 2018

Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey. Drug Safety 39(12): 1239-1250, 2016

Knowledge, Attitudes, and Practices of Health Care Professionals Toward Adverse Drug Reaction Reporting in Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia: A Cross-sectional Study. Hospital Pharmacy 53(3): 177-187, 2018

Effect of educational intervention on adverse drug reporting by physicians: a cross-sectional study. Isrn Pharmacology 2014: 259476, 2014

Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register. Drug Safety 34(8): 669-682, 2011

A cross-sectional study of adverse drug reactions reporting among doctors of a private medical college in Bihar, India. Indian Journal of Pharmacology 47(1): 126-127, 2015

Cross-sectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh. Bmj Open 6(8): E010912, 2017

Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring. Zhongguo Zhong Yao Za Zhi 37(18): 2686-2688, 2013

Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients. European Journal of Clinical Pharmacology 72(5): 605-614, 2017

Traceability of biopharmaceuticals in spontaneous reporting systems: a cross-sectional study in the FDA Adverse Event Reporting System (FAERS) and EudraVigilance databases. Drug Safety 36(8): 617-625, 2014

Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study. Plos One 12(10): E0186631, 2017

Mortality from adverse drug reaction-related hospitalizations in south-west Ethiopia: A cross-sectional study. Journal of Clinical Pharmacy and Therapeutics 43(6): 790-798, 2018

Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals. Drug Safety 40(7): 597-606, 2017

Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: a cross-sectional study. Emergency Medicine Journal 31(1): 24-29, 2014

Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project. JAMA 263(13): 1785-1788, 1990